Outcome of Board meeting under Regulation 30 of SEBI(Listing Obligations and disclosures Requirements), regulations 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Kimia Biosciences Ltd, at its meeting held on December 2, 2025, approved the appointment of M/s M & Co., led by Company Secretary Maghisuddin, as the new Secretarial Auditor of the company. The appointment is to fill a 'casual vacancy' for the financial year 2025-26, meaning the previous secretarial auditor stepped down before their term ended. The new auditor will hold office until the conclusion of the next Annual General Meeting. M & Co. has over 8 years of experience in corporate and securities law advisory and is a peer-reviewed firm. No change in director relationships was disclosed as part of this appointment.
The phrase 'casual vacancy' indicates the prior secretarial auditor left mid-term, which investors may want to monitor for any underlying governance concerns. However, the new appointment itself is a routine compliance action and is unlikely to materially affect the stock price.